Log In

G-597

Molecular Epidemiology and Antibiotic-Resistance of Bacterial Infections in Georgia

Project Status: 8 Project completed
Commencement Date: 01.01.2002
Duration in months: 42 months

Objective

The emergence of pathogenic bacteria resistant to most currently available antimicrobial agents represents one of the most critical problems in modern medicine. The problem is of particular concern in the newly independent Republic of Georgia, where the uncontrolled use of antibiotics, combined with a deteriorating public heath infrastructure accompanying the disintegration of the former Soviet Union, has resulted in the extensive emergence of antibiotic-resistant strains of pathogenic bacteria. This opinion of the Georgian Ministry of Health was substantiated recently, when a panel of US experts found, during the recent joint US-Georgia Workshop in Emerging Infectious Diseases (held in Tbilisi in 1998), the problem of antibiotic resistance to be the # 1 public health problem in Georgia. The panel subsequently strongly recommended that a rigorous program should be developed to address this problem as soon as possible.

This proposal is designed to address several critical aspects of the problem of antimicrobial resistance in Georgia, with the ultimate goal of limiting the development of bacterial resistance in, and its spread from, this developing country. The proposal is based on a strong research component and involves close collaboration between Georgian researchers and investigators in the United States. More specifically, four major tasks will be jointly addressed:

1. A central laboratory-based surveillance will be undertaken in Georgia for three major nosocomial pathogens of particular public health concern (“strains of interest”), including enterococci (with an emphasis on E. faecalis and E. faecium), S. aureus, and P. aeruginosa.

2. Antibiotic-resistance patterns of the strains of interest will be determined using modern antimicrobial susceptibility-testing techniques (conventional and genetic-based), with appropriate quality control performed at the University of Maryland.

3. Molecular subtyping of the strains of interest will be performed by pulsed field gel electrophoresis (PFGE) and randomly amplified polymorphic DNA (RAPD) techniques, and internet-based data exchange capabilities will be established at the NCDC; in addition, a novel typing methodology based on the multilocus sequence typing (MLST) technique will be developed for enterococci, and the enterococcal strains isolated in Georgia and the United States will be comprehensively analyzed for the first time by this novel approach.

4. Educational materials (e.g., brochures and handouts) about the judicious use of antibiotics will be developed and distributed to all major hospitals and medical centers in Georgia.

As a result of these activities, several Georgian scientists previously engaged in research associated with biological warfare will be able to redirect their activities to address one of the most urgent Georgian and global public health concerns, and they will have an opportunity to integrate their talents into the international scientific community. In addition, the successful completion of the project will significantly improve antibiotic-resistance testing capabilities in Georgia and will provide rigorous data about multidrug-resistant bacteria in the country – which will be critical for designing proper control and implementation strategies to prevent the spread of antibiotic-resistant bacteria in Georgia and to other countries from Georgia.

Furthermore, a new typing methodology for characterizing enterococci will be developed based on the MLST approach, which will provide a means for:


– better understanding the epidemiology of these bacteria and the mechanisms of spread of antibiotic-resistance (specifically against vancomycin) in enterococci;
– delineating phylogenetic relationships between enterococcal strains isolated in Georgia and the United States.

From a basic science standpoint, data generated during the project will:


– broaden our understanding of the mechanisms for the development of antimicrobial resistance;
– will provide insight into the possible links between the use of certain antibiotics and development of resistance;
– may lead to the identification of new resistance mechanisms/genes in a bacterial population that has not been previously available to US researchers for detailed analysis.

Participating Institutions

LEADING

National Center for Disease Control and Public Health (NCDC)